Skip to main content

Intranasal Delivery of the Peptide, Salmon Calcitonin

  • Chapter
Delivery Systems for Peptide Drugs

Part of the book series: NATO ASI Series ((NSSA,volume 125))

Abstract

Calcitonin is a polypeptide hormone normally secreted by the parafollicular cells of mammalian thyroid glands and by the ultimobronchial gland of birds and fish. The linear sequence of 32 amino acids found in the calcitonin of salmon origin has been synthesized. This synthetic salmon calcitonin (sCT) is currently formulated as a sterile solution for subcutaneous injection in the treatment of Paget’s disease, hypercalcemia, and osteoporosis. Paget’s disease is a disorder characterized by abnormal bone formation and resorption while hypercalcemia is an elevated serum calcium level, and osteoporosis is a loss of bone mass with increased fractures. Treatment calls for daily subcutaneous injections of salmon calcitonin over an extended period. The necessity of this daily injection is bothersome and inconvenient to patients. However, because the drug is a polypeptide subject to digestive degradation, it can not be given orally. Therefore, an alternate route of administration, such as intranasally, is attractive.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • B’hend, P., Hadron, B., Haldeman, B., Klebb, M., and Luthi, H., 1973, Stimulation of pancreatic secretion in man by secretin snuff, Lancet, i:510.

    Google Scholar 

  • Felber, J., Aubert, M., and Deguillaume, R., 1969, Administration by nasal spray of an 18 amino acid synthetic polypeptide with corticotrophic action, Experimentia, 25: 1195.

    Article  CAS  Google Scholar 

  • Hendrick, C. and Gabel, R., 1960, Use of intranasal oxytocin in obsterics, Am. J. Obstet. Gynec., 79: 780.

    Google Scholar 

  • Hirai, S., Ikenaga, T., and Matsuzana, T., 1978, Nasal absorption of insulin in dogs, Diabetes, 27: 296.

    Article  CAS  Google Scholar 

  • Hirai, S., Yashiki, T., and Mima, H., 1978, Effect of surfactants on the nasal absorption of insulin in rats, Int. J. Pharm., 9: 165.

    Google Scholar 

  • Hirai, S., Yashiki, T. and Mina, H., 1978, Mechanism for the enhancement of the nasal absorption of insulin by surfactants, Int. J. Pharm., 9:173.

    Google Scholar 

  • Hussain, A., Hirai, S., and Bawarshi, R., 1979, Nasal absorption of propranolol in rats, J. Pharm. Sci., 68: 1196.

    Article  PubMed  CAS  Google Scholar 

  • Hussain, A., Foster, T., Hirai, S., Kashihara, T., Batenhorst, R., and Jones, M., 1980, Nasal absorption of propranolol in humans, J. Pharm. Sci., 69: 1240.

    Article  PubMed  CAS  Google Scholar 

  • Hussain, A., Hirai, S., and Bawarshi, R., 1980, Nasal absorption of propranolol from different dosage forms by rats and dogs, J. Pharm. Sci., 69: 1411.

    Article  PubMed  CAS  Google Scholar 

  • Hussain, A., Hirai, S., and Bawarshi, R., 1981, Nasal absorption of natural contraceptive steroids in rats — progesterone absorption, J. Pharm. Sci., 70: 466.

    Article  PubMed  CAS  Google Scholar 

  • Keenan, J., Thompson, J., Chamberlain, M. and Bessir, G., 1971, Prolonged corticotrophic action of a synthetic substituted 1–18 ACTH, Brit. Med. J., 3: 742.

    Article  PubMed  CAS  Google Scholar 

  • London, D., Butt, W., and Marshall, J., 1973, Intranasal LH-releasing harmone, Lancet, i:1258.

    Google Scholar 

  • Potashnik, G., Ben-Adereth, N., Lunenfeld, B., and Rote, C., 1977, Nasal application of synthetic gonadotropin-releasing hormone in men, Fertil. Steril., 28: 650.

    PubMed  CAS  Google Scholar 

  • Smith, R., 1952, Nasal administration of ACTH: observation of effectiveness measured by blood eosinopenic response, Endocrine Soc. Abst., 12:958.

    Google Scholar 

  • Ziegler, R., Holz, G., Steribl, W., and Raue, F., 1978, Nasal application of calcitonin in Paget’s disease of bone, Acta Endroc. Suppl., 215: 54.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1986 Springer Science+Business Media New York

About this chapter

Cite this chapter

Hanson, M., Gazdick, G., Cahill, J., Augustine, M. (1986). Intranasal Delivery of the Peptide, Salmon Calcitonin. In: Davis, S.S., Illum, L., Tomlinson, E. (eds) Delivery Systems for Peptide Drugs. NATO ASI Series, vol 125. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-9960-6_19

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-9960-6_19

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4757-9962-0

  • Online ISBN: 978-1-4757-9960-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics